IMMUNOLOGICAL AND CLINICAL SURVEILLANCE IN RECKLINGHAUSENS NEUROFIBROMATOSIS (NF1)

Authors
GEROSA PL VAI C BIZZOZERO L FONTANA A GIUSSANI G SPINELLI M
Citation
Pl. Gerosa et al., IMMUNOLOGICAL AND CLINICAL SURVEILLANCE IN RECKLINGHAUSENS NEUROFIBROMATOSIS (NF1), Panminerva Medica, 35(2), 1993, pp. 80-85
Citations number
NO
Categorie Soggetti
Medicine, General & Internal
Journal title
Panminerva Medica → ACNP
ISSN journal
00310808
Volume
35
Issue
2
Year of publication
1993
Pages
80 - 85
Database
ISI
SICI code
0031-0808(1993)35:2<80:IACSIR>2.0.ZU;2-5
Abstract
Neurofibromatosis evolution is described in relation to the factors th at may favour its expansion and immune modifications. NF1 monitorizati on should employ periodic clinical and immune surveillance. Such an ap proach would allow the application of immunomodulating treatment (e.g. adapted therapy) only when indicated, thereby reducing its duration a nd potentiating its efficacy.